Molecular formula: | C26H27FN10 |
Average mass: | 498.570 |
Monoisotopic mass: | 498.240419 |
ChemSpider ID: | 58828673 |
1 of 1 defined stereocentres
(1S)-1-(4-Fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl}-5-pyrimidinyl)ethanamine
[ACD/IUPAC Name](1S)-1-(4-Fluorophényl)-1-(2-{4-[6-(1-méthyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-pipérazinyl}-5-pyrimidinyl)éthanamine
[French]
[ACD/IUPAC Name](1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethan-1-amine
(1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethanamine
(1S)-1-(4-Fluorphenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl}-5-pyrimidinyl)ethanamin
[German]
[ACD/IUPAC Name]1703793-34-3
[RN]5-Pyrimidinemethanamine, alpha-(4-fluorophenyl)-alpha-methyl-2-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl]-, (alphaS)-
[ACD/Index Name]513P80B4YJ
avapritinib
[INN] [USAN]avapritinib
[French]
[INN]avapritinib
[Spanish]
[INN]avapritinibum
[Latin]
[INN]Ayvakit
[Trade name]авапритиниб
[Russian]
[INN]أفابريتينيب
[Arabic]
[INN](S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine
(αS)-(4-fluorophenyl)-α-methyl-2-[4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl]-5-pyrimidinemethanamine
95%
ABCG2_HUMAN
avapritinibum
KIT_HUMAN
MFCD31544325
[MDL number]PGFRA_HUMAN
US10807985, Compound 44
авапритиниб
أفابريتينيب
阿伐替尼
[Chinese]